ClinicalTrials.Veeva

Menu

Alternations of Intestinal Microbiota and Health Impact in CKD

B

Buddhist Tzu Chi Medical Foundation

Status

Unknown

Conditions

Chronic Kidney Disease

Study type

Observational

Funder types

Other

Identifiers

NCT03794401
07-XD-074

Details and patient eligibility

About

This study is aimed to evaluate the impact of dietary pattern, gut microbiota and their interactions on clinical outcomes among patient with CKD stage 3-5.

Enrollment

750 estimated patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with CKD stage 3-5 defined as eGFR <60 ml/min/1.73 m2 calculated with the use of the four-variable Modification of Diet in Renal Disease formula who have not yet on dialysis therapy.

Exclusion criteria

  • Patients with active cancer
  • Patients with liver cirrhosis
  • Patients have taken antibiotics within three months before screening for inclusion.
  • Patients with a cardiac pacemaker or metallic implants,
  • Patients are amputees
  • Pregnant women
  • Patients with inherited renal diseases

Trial contacts and locations

1

Loading...

Central trial contact

TING-YUN LIN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems